Word

ECLIPSYS

Status

Registered

Status Code

700

Status Date

Tuesday, October 3, 2023

Serial Number

97409708

Registration Number

7179544

Registration Date

Tuesday, October 3, 2023

Mark Type

4000

Filing Date

Friday, May 13, 2022

Published for Opposition

Tuesday, July 18, 2023

Trademark Owner History

Amphista Therapeutics Limited - Original Registrant

Classifications

5 Pharmaceuticals, medicinal and veterinary preparations for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; diagnostic preparations for medical and veterinary use; medicines and biotechnological preparations for medical use for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; biological and chemical reagents for medical use; pharmaceutical drugs for medical purposes for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; none of the aforesaid goods being for the treatment and care of wounds and none of the aforesaid relating to reagents and chemicals for use in relation to biochemicals, oligonucleotides, oligonucleotide conjugates, DNA primers, DNA, genetic, and oligonucleotide probes, and quenchers

1 Chemicals for use in science; chemical compositions and agents for use in science; chemical preparations for use in the manufacture of pharmaceutical drugs; biological preparations for use in science; chemicals for biotechnological manufacturing processes; diagnostic preparations used for scientific or research use; reagents used for scientific or research use; proteins in raw material form for scientific or research use; none of the aforesaid relating to reagents and chemicals for use in relation to biochemicals, oligonucleotides, oligonucleotide conjugates, DNA primers, DNA, genetic, and oligonucleotide probes, and quenchers

42 Scientific and technological services, namely, scientific analysis, testing, engineering, development, research, and design in the field of drug discovery and the identification and development of pharmaceutical and medicinal preparations; consultancy relating to product research and development in the field of pharmaceutical and medicinal preparations for therapeutic use; research and development in the field of medical diagnostics; biotechnological and chemical testing; research and development in the pharmaceutical, chemical and biotechnological fields; research and development in the field of medicinal preparations; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical drug development services; none of the aforesaid relating to reagents and chemicals for use in relation to biochemicals, oligonucleotides, oligonucleotide conjugates, DNA primers, DNA, genetic, and oligonucleotide probes, and quenchers

Trademark Events

Oct 3, 2023

Notice Of Registration Confirmation Emailed

Oct 3, 2023

Registered-Principal Register

Jul 18, 2023

Official Gazette Publication Confirmation E-Mailed

Jul 18, 2023

Published For Opposition

Jun 28, 2023

Notification Of Notice Of Publication E-Mailed

Jun 12, 2023

Approved For Pub - Principal Register

Jun 1, 2023

Teas/Email Correspondence Entered

May 31, 2023

Correspondence Received In Law Office

May 31, 2023

Teas Response To Office Action Received

Mar 3, 2023

Notification Of Non-Final Action E-Mailed

Mar 3, 2023

Non-Final Action E-Mailed

Mar 3, 2023

Non-Final Action Written

Mar 2, 2023

Assigned To Examiner

Feb 15, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Feb 15, 2023

Teas Change Of Correspondence Received

Feb 15, 2023

Teas Change Of Owner Address Received

Feb 14, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Feb 14, 2023

Teas Change Of Correspondence Received

Feb 14, 2023

Teas Change Of Domestic Representatives Address

Feb 14, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Feb 14, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Feb 14, 2023

Teas Change Of Owner Address Received

Jun 2, 2022

Teas Amendment Entered Before Attorney Assigned

Jun 2, 2022

Teas Voluntary Amendment Received

May 18, 2022

New Application Office Supplied Data Entered

May 17, 2022

New Application Entered